The use of lymphocyte phosphoglucomutase as a genetic marker in bone marrow transplant recipients.

Lymphocyte phosphoglucomutase can be used as a genetic marker to document successful engraftment in bone marrow transplant recipients. Two patients who underwent marrow transplantation as a treatment for acute leukemia showed a change into donor-type isozyme pattern.